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pts were subdivided into older ('2:40) and younger «40) groups. Freedom
from TxCAD was 92%, 52%, and 43% at 1, 3, and 5 years post-op in the
older group In = 31, mean age 49) vs. 97%, 82%, and 53% in the younger
group (n = 184, mean age 24) p = 0.03 (Mantel-Haenszel).
Baseline ICUS imaging revealed baseline class 3 or 4 lesions in 7 of 9
older donor hearts, and in only 7 of 32 younger hearts (p = 0.006). Three
of these 14 ICUS class 3/4 pts later developed TxCAD vs. only 3 of 27 class
1/2 pts at baseline (p = NS). Older donor age, no calcium blocker use and
pre-existing CAD were significant predictors for development of TxCAD (p =
0.0006,0.0003, and 0.003 respectively, Cox regression analysis).
Conclusion: (1) Older donors or pre-existing CAD have a greater tendency
to develop TxCAD, (2) ICUS reveals moderate to severe intimal thickening not
angiographically detectable and there is a trend toward such disease leading
to later TxCAD.
Transplant coronary arteriopathy is the major obstacle to long-term survival
of cardiac allografts and is characterized by myointimal proliferation involv-
ing both epicardial conduit vessels and intramyocardial resistance vessels.
To evaluate the relationship between conduit disease and resistance vessel
integrity, 70 coronary arteries in 58 transplant patients were studied with a
3.5 Fr 30 MHz intravascular ultrasound (IVUS) probe and an 0.018" doppler
guidewire. Epicardial conduit disease was characterized by the presence or
absence of IVUS discernible intimal thickening, (>500 microns or <500 mi-
cronsl in either a diffuse (trilaminar appearance along whole course of stud-
ied segment) or a focal (with areas of vessel free of intimal thickening) dis-
tribution. Resistance vessel function was assessed by measuring coronary
flow reserve (CFR ~ maximal hypermiclresting blood flow velocity) using in-
tracoronary adenosine (18 mg). Results (means ± SD):
There were no differences in the CFR between arteries with (n = 58) and
without (n = 12) intimal thickening (3.2 ± 0.6 vs 3.1 ± 0.5; P ~ NSI or based
on the maximal thickness of the intima «500 microns, 3.2 ± 8 vs >500 mi-
crons 3.0 ± 0.7, P = NS). Extensive myointimal thickening can occur without
diminishment of the CFR. Focal intimal disease is associated with a signif-
icantly more profound effect on microvascular function then classically de-
scribed diffuse disease. This suggests that typical epicardial transplant arte-
riopathy can occur without involvement of small vessels.
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Dobutamine stress echocardiography (DSE) is a noninvasive and safe test
to detect myocardial ischemia. To analyse, if DSE is feasible for assessment
and follow up of coronary allograft vasculopathy (CAV), 13 patients (R 50
+/~ 8 years, 60 +1= 32 months after heart transplantation) were studied
at 2 consecutive routine annual investigations by coronary angiography (AN-
GlO), intravascular ultrasound (IVUS quantitative analysis of degree and ex-
tension of intimal hyperplasia; modified Stanford grading, grades 1--B) and
dobutamine stress echocardiography(DSE, 5-40 mcglkg/min, 5 min stages).
Regional wall motion abnormalities (WMA) were assessed qualitatively (2-D-
echo, 16 segment model1and quantitatively 1M-Mode, systolic thickening of
interventricular septum (IVS) and LV posterior wall (LPW)I.
Results: P were allocated to 2 groups: group 1, normal DSE at entry (n
= 9); group 2, WMA during DSE at entry (n = 4). At the initial study, no
P had WMA at rest. In group 1, IVUS revealed only mild intimal hyperplasia
Imean, < grade 3.5) in group-l P; ANGlO was completely normal in 8/9 P and
showed mild dilating angiopathy in 119 P. 4 group-2 Pdeveloped WMA during
DSE (total, 12/64 segments); ANGlO was normal in all R IVUS grades were
1.2/1.714.0/5.5. Mean systolic thickening of IVS (rest, 26 vs. 32%; max.DSE,
37 vs. 63%, group 2 vs. 1) and LPW (rest, 35 vs 57% max.DSE, 65 vs. 95%)
were smaller in group 2 than in group 1. At follow up, 3/9 group-l P had DSE-
induced WMA (9/144 segments); all had IVUS progression to grade >3.5,
but no ANGlO changes. In group 2, 1 P with stress induced WMA in only
one segment at entry was judged normal at follow up IIVUS: 1.2 and 1.6,
respectively; false positive DSE at entry). 3 group-2 P deteriorated 1 had
diffuse WMA at rest, all 3 had increasing WMA at DSE (total. 26/48 segments.
Mean IVUS grades rose to 4.015.5/6.0; ANGlO remained normal in 2 P and
showed diffuse rarefication of small vessels in 1 P.
Conclusion: All P with marked-to-severe intimal hyperplasia assessed by
IVUS andlor marked ANGlO findings were identified by DSE. Serial DSE is a
feasible and safe method for noninvasive screening and follow-up for CAy in
heart transplant recipients. In Pwith normal DSE, the need for routine ANGlO
at regular intervals may be reduced.
jection, we hypothesized that atherothrombotic risk factors may contribute
to accelerated atherosclerosis. We therefore prospectively evaluated the
burden of coronary atherosclerosis by intravascular ultrasound (IVUS) in 20
patients and measured plasma fibrinogen (FGNl. lipoprotein (a) (Lp(a)) and
net fibrinolytic activity of plasma using a standard fibrin plate assay. Inti-
mal thickening was quantified using IVUS by measuring the intimal index
(Ii = intimal areal[intimal area + luminal area]) in 2-5 segments of the LAD
using planimetry. The maximal Ii per patient was calculated and indexed
to the time post-transplant (MxlilYr). FGN predicted severity of MxlilYr (r2
= 0.41, p = 0.008). In patients with decreased plasma fibrinolytic activity
(lytic zone < 100 mm21. MxlilYr was increased ten-fold 10.21 ± 0.17 vs.
0.02 ± 0.02, p = 0.002). Because Lp(a) colocalizes with fibrinogen in the
vessel wall and inhibits fibrinolysis, we correlated plasma Lp(a) levels with
the degree of intimal thickening. Lp(a) did not predict MxlilYr (p = NS). In
conclusion, these data suggest that plasma FGN and net fibrinolytic activity
predict the degree of intimal thickening and that fibrin deposition may play
an integral role in diffuse coronary atherosclerosis after cardiac transplan-
tation.
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The increasing demand for cardiac donors has led to a tendency to liberalize
age and other criteria for donor acceptability. Since cardiac allograft coro-
nary artery disease (TxCADI is the major complication limiting longterm post-
transplant survival, we analyzed a series of 242 consecutive cardiac trans-
plant patients (Tx pts) who had baseline early post-op coronary angios and a
subset of 41 pts with baseline intracoronary ultrasound IICUSI to determine
whether either older donor age or pre-existing CAD at the time of transplant
influenced the later occurrence of TxCAD.
Fourteen pts had angiographic evidence of some pre-existing CAD Idonor
CAD group); the other 228 did not (no donor CAD group). New disease was
defined as either development of new obstructive lesions or progression of
old lesions on serial annual angios. Freedom from new disease was 86%,
71 %, and 30% at 1, 2, and 3 years post-op in the donor CAD group and
97%,89%, and 77% in the no donor CAD group (p ~ 0.0031. No donor CAD
Accelerated arteriosclerosis in transplanted organs represents the major
cause of graft failure and is limiting the clinical outcome of heart transplan-
tation.
Using a rat aorta transplant model the impact of cold ischemia time up to
24 hours (extracorporal storage time) and reperfusion injury upon develop-
ment of transplant arteriosclerosis was analysed during the first 2 months
after transplantation both in allogeneic as well as in syngeneic transplants.
The expression of the various isoforms of transforming growth factor-p (TGF-
P), latent TGF-p binding protein (LTBPI as well as platelet-derived growth
factor (pDGF) and its receptors were studied using immunohistochemistry,
followed by a semi-quantitative evaluation and multivariant analysis (n = 18
for each antiserum).
In the syngeneically transplanted aortas the expression of TGF-pl (p <
0031, PDGF-BB (p < 0.05) and of the PDGF a-receptor(p < 0.03) in the neoin-
tima increased significantly with the extent of cold ischemia time. Further-
more, there was a significant induction of LTBP (p < 0.05) correlating with
the observation time after transplantation. In the allogeneic aortic grafts, ex-
pression of all examined proteins was increased soon after transplantation.
In summary, TGF-p and PDGF are induced by allogeneic as well as is-
chemic stimuli in transplanted vessels. Moreover, in the syngeneic trans-
plantation model, cold ischemia time prior to implantation has an impact on
the expression of growth factors and the extent of vascular remodeling.
